Celularity Inc. Short-term Debt, Fair Value
Celularity Inc. (CELU) had Short-term Debt, Fair Value of $2.48 million as of 2024-12-31, per its 10-K filed 2025-05-08.
Financial Statements › Notes
us-gaap:ShorttermDebtFairValue · last filed 2025-05-08
- 2024-12-31: Short-term Debt, Fair Value $2.48M.
- 2024-09-30: Short-term Debt, Fair Value $3.69M.
- 2024-06-30: Short-term Debt, Fair Value $2.98M.
- 2024-03-31: Short-term Debt, Fair Value $2.18M.
| Period end | Short-term Debt, Fair Value |
|---|---|
| 2024-12-31 | $2.48M 10-K · filed 2025-05-08 |
| 2024-09-30 | $3.69M 10-Q · filed 2024-12-06 |
| 2024-06-30 | $2.98M 10-Q · filed 2024-11-07 |
| 2024-03-31 | $2.18M 10-Q · filed 2024-10-16 |
| 2023-12-31 | $17.22M 10-K · filed 2025-05-08 |
| 2023-09-30 | $14.01M 10-Q · filed 2024-01-03 |
| 2023-06-30 | $16.82M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $30.95M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $37.60M 10-K · filed 2024-07-30 |
| 2022-09-30 | $39.26M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |